The Christie Private Care invest in a new robot for cancer surgery

The da Vinci xi is the latest addition to The Christie Private Care’s new £7.8 million state of the art theatres, and is the only da Vinci robot in the independent sector in the region.

The Christie Private Care, part of HCA Healthcare UK, has today announced the acquisition of the most advanced robotic integrated surgical system, the da Vinci Xi , bringing a level of minimally invasive complex cancer surgery to private patients not available elsewhere in the region.
 
The market-leading da Vinci surgical system, has been designed to provide surgeons with greater flexibility and precision across a wide range of minimally-invasive surgical procedures – leading to quicker recovery times, less post-operative pain, and lower rates of surgical complications for patients.  

Unlike other systems on the market, firefly fluorescence imaging has been built into the da Vinci Xi robot to give surgeons real-time visualisation and assessment of vessels, bile ducts, and tissue perfusion – allowing them to operate more easily across multiple quadrants of the body and giving them better access during complex procedures. 

The da Vinci Xi is the latest addition to The Christie Private Care’s newly installed state-of-the-art   £7.8 million theatres.  The opening of the theatres marks another milestone HCA UK’s 10- year partnership with The Christie NHS Foundation Trust, giving independently funded patients access to specialist acute cancer care, whilst generating resources that can be reinvested into NHS services. 

 Claire Smith, CEO, HCA UK Joint Ventures said:  

“Across HCA Healthcare UK we are always working to ensure that our patients have access to the best possible care and range of specialist treatment options. By investing in our theatres at The Christie Private Care and acquiring the most advanced robotic surgical system, we have enhanced our capability even further, opening up new routes to minimally invasive and complex surgery and our incredible teams of surgeons and theatre teams. 

“We are incredibly proud to be the first in the region to offer this technology in the independent sector ensuring that when it comes to cancer care, we are uniquely positioned to be able to support patients throughout their clinical pathway.” 

Mr Aziz Gulamhusein, Consultant Urological and Robotic Surgeon, who recently performed a Robotic-assisted Partial Nephrectomy using the da Vinci Xi at The Christie Private Care said:  

“Over the last 10 years we have seen real advancements in the capability of robotic surgery and for many cancers, where clinically possible, this is now considered the gold standard of treatment. The da Vinci Xi is the latest robotic platform, and this enhanced technology means as surgeons we can gain different visual perspectives, and reach different angles, allowing us to operate with greater precision than ever before. 

“This investment means we are now able to offer more patients access to timely robotic surgical treatment, provided by expert and highly skilled clinical teams, helping to provide excellent outcomes with rapid recovery."